✦ LIBER ✦

QT as a Safety Biomarker in Drug Development

✍ Scribed by Whellan, DJ; Green, CL; Piccini, JP; Krucoff, MW

Book ID: 109845952
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 121 KB
Volume: 86
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2009.70

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers in Clinical Drug Development

✍ Gobburu, JVS 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Biomarker method validation in anticance

Biomarker method validation in anticancer drug development

✍ J Cummings; T H Ward; A Greystoke; M Ranson; C Dive 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 194 KB

Imaging biomarkers as surrogate endpoint

Imaging biomarkers as surrogate endpoints for drug development

✍ Wolf S. Richter 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 100 KB

Proteomics in biomarker discovery and dr

Proteomics in biomarker discovery and drug development

✍ Qing-Yu He; Jen-Fu Chiu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract Proteomics is a research field aiming to characterize molecular and cellular dynamics in protein expression and function on a global level. The introduction of proteomics has been greatly broadening our view and accelerating our path in various medical researches. The most significant a

Towards consensus practices to qualify s

Towards consensus practices to qualify safety biomarkers for use in early drug development

✍ Sistare, Frank D; Dieterle, Frank; Troth, Sean; Holder, Daniel J; Gerhold, David 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 307 KB

Biomarkers in Alzheimer's disease drug d

Biomarkers in Alzheimer's disease drug development

✍ Blennow, Kaj 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 663 KB